![Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights | BMC Microbiology | Full Text Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights | BMC Microbiology | Full Text](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12866-023-02911-z/MediaObjects/12866_2023_2911_Fig3_HTML.png)
Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights | BMC Microbiology | Full Text
![Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights | BMC Microbiology | Full Text Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights | BMC Microbiology | Full Text](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12866-023-02911-z/MediaObjects/12866_2023_2911_Fig5_HTML.png)
Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights | BMC Microbiology | Full Text
![Lactobacillus rhamnosus GG Regulates Host IFN-I Through the RIG-I Signalling Pathway to Inhibit Herpes Simplex Virus Type 2 Infection | Probiotics and Antimicrobial Proteins Lactobacillus rhamnosus GG Regulates Host IFN-I Through the RIG-I Signalling Pathway to Inhibit Herpes Simplex Virus Type 2 Infection | Probiotics and Antimicrobial Proteins](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12602-023-10137-8/MediaObjects/12602_2023_10137_Figa_HTML.png)
Lactobacillus rhamnosus GG Regulates Host IFN-I Through the RIG-I Signalling Pathway to Inhibit Herpes Simplex Virus Type 2 Infection | Probiotics and Antimicrobial Proteins
![PDF) Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study PDF) Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study](https://i1.rgstatic.net/publication/319366713_Comparison_of_Acyclovir_and_Multistrain_Lactobacillus_brevis_in_Women_with_Recurrent_Genital_Herpes_Infections_a_Double-Blind_Randomized_Controlled_Study/links/59d1e8f8a6fdcc181ad5d98e/largepreview.png)
PDF) Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study
![IJERPH | Free Full-Text | Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis IJERPH | Free Full-Text | Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis](https://www.mdpi.com/ijerph/ijerph-17-08891/article_deploy/html/images/ijerph-17-08891-g001.png)
IJERPH | Free Full-Text | Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis
![PDF) Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study PDF) Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study](https://www.researchgate.net/profile/Sedigheh-Taghinezhad-Saroukalaei/publication/319366713/figure/fig4/AS:962385493884929@1606461990203/Boxes-represent-the-median-distribution-of-the-HSV-2-DNA-copy-number-log10-copies-mL-as_Q320.jpg)
PDF) Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study
![Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study | Probiotics and Antimicrobial Proteins Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study | Probiotics and Antimicrobial Proteins](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12602-017-9320-8/MediaObjects/12602_2017_9320_Fig3_HTML.gif)
Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study | Probiotics and Antimicrobial Proteins
![Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study | Probiotics and Antimicrobial Proteins Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study | Probiotics and Antimicrobial Proteins](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12602-017-9320-8/MediaObjects/12602_2017_9320_Fig1_HTML.gif)
Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study | Probiotics and Antimicrobial Proteins
![Acyclovir for Injection 50 mg/mL Single-Dose Vials 20 mL x 10/Box (Rx) — Mountainside Medical Equipment Acyclovir for Injection 50 mg/mL Single-Dose Vials 20 mL x 10/Box (Rx) — Mountainside Medical Equipment](https://www.mountainside-medical.com/cdn/shop/files/Acyclovir-for-Injection-50-mg-mL-Single-Dose-Vials-20-mL.jpg?v=1685710063)
Acyclovir for Injection 50 mg/mL Single-Dose Vials 20 mL x 10/Box (Rx) — Mountainside Medical Equipment
![IJERPH | Free Full-Text | Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis IJERPH | Free Full-Text | Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis](https://pub.mdpi-res.com/ijerph/ijerph-17-08891/article_deploy/html/images/ijerph-17-08891-g005.png?1607485256)
IJERPH | Free Full-Text | Antiviral Agents for the Prevention and Treatment of Herpes Simplex Virus Type-1 Infection in Clinical Oncology: A Network Meta-Analysis
![Acyclovir for Injection 50 mg/mL Single-Dose Vials 10 mL x 10/Box (Rx) — Mountainside Medical Equipment Acyclovir for Injection 50 mg/mL Single-Dose Vials 10 mL x 10/Box (Rx) — Mountainside Medical Equipment](https://www.mountainside-medical.com/cdn/shop/files/Acyclovir-for-Injection-50-mL-Single-Dose-Vials.jpg?v=1685709044)